PATH-18. SUBCLASSIFICATION OF LOW-GRADE GLIOMAS CONSIDERING TERT PROMOTER MUTATION AND ATRX LOSS: BEYOND THE 2016 WHO CLASSIFICATION

BACKGROUND: Grade II glioma is a heterogeneous group of various pathologies. 2016 WHO classification defined subgroups of Grade II gliomas based on isocitrate dehydrogenase (IDH) mutation and 1p/19q codeletion status. However, implications of telomerase reverse transcriptase promoter (TERTp) mutatio...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Hee Chang, Jong, Hoon Roh, Tae, Hyung Moon, Ju, Hyun Kim, Eui, Kang, Seok-Gu, Hoon Kim, Se, Suh, Chang-Ok
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Abstracts
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216526/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.674
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires